Cargando…

Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial

INTRODUCTION: Many smoking cessation aids such as nicotine replacement treatments and e-cigarettes have been proven effective in aiding smoking cessation attempts. Encouraging smokers with low socioeconomic position (SEP) to choose their smoking aid tool based on their preferences, and giving that t...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Khoury, Fabienne, El Aarbaoui, Tarik, Héron, Mégane, Hejblum, Gilles, Métadieu, Brigitte, Le Faou, Anne-Laurence, Ibanez, Gladys, Melchior, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246378/
https://www.ncbi.nlm.nih.gov/pubmed/34193499
http://dx.doi.org/10.1136/bmjopen-2021-048859
_version_ 1783716300316475392
author El-Khoury, Fabienne
El Aarbaoui, Tarik
Héron, Mégane
Hejblum, Gilles
Métadieu, Brigitte
Le Faou, Anne-Laurence
Ibanez, Gladys
Melchior, Maria
author_facet El-Khoury, Fabienne
El Aarbaoui, Tarik
Héron, Mégane
Hejblum, Gilles
Métadieu, Brigitte
Le Faou, Anne-Laurence
Ibanez, Gladys
Melchior, Maria
author_sort El-Khoury, Fabienne
collection PubMed
description INTRODUCTION: Many smoking cessation aids such as nicotine replacement treatments and e-cigarettes have been proven effective in aiding smoking cessation attempts. Encouraging smokers with low socioeconomic position (SEP) to choose their smoking aid tool based on their preferences, and giving that tool free of charge, might increase the odds of smoking cessation. This trial examines the effectiveness of the ‘STOP’ (Sevrage Tabagique à l’aide d’Outils dédiés selon la Préférence: Smoking cessation using preference-based tools), a preference-based smoking cessation intervention for smokers with low SEP. METHODS AND ANALYSIS: The STOP study is a randomised, multicentre, controlled trial (RCT). Smokers with low SEP and wishing to quit will be randomised to either the intervention or the control group (standard care). Participants in the intervention group will be asked to choose between different types of nicotine substitutes (patches, inhalers, gum, tablets, etc) and/or an electronic cigarette which will be delivered free of charge to aid their smoking cessation attempt. The primary outcome will be smoking abstinence at 6 months after inclusion, defined as self-reported 7-day point prevalence of tobacco abstinence. Secondary outcomes include the total number of days of abstinence at 6 months after inclusion, 7-day point prevalence tobacco abstinence at 1 and 3 months after inclusion and number of relapses. The study will also include an economic evaluation, and a process evaluation using a mixed methods approach. ETHICS AND DISSEMINATION: The study was approved by the ‘Île de France II’ Institutional Review Board on 8 September 2020 (CPP Île de France II; Ref No: 20.01.31.65528 RIPH2 HPS), and results will be published in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT04654585.
format Online
Article
Text
id pubmed-8246378
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82463782021-07-13 Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial El-Khoury, Fabienne El Aarbaoui, Tarik Héron, Mégane Hejblum, Gilles Métadieu, Brigitte Le Faou, Anne-Laurence Ibanez, Gladys Melchior, Maria BMJ Open Addiction INTRODUCTION: Many smoking cessation aids such as nicotine replacement treatments and e-cigarettes have been proven effective in aiding smoking cessation attempts. Encouraging smokers with low socioeconomic position (SEP) to choose their smoking aid tool based on their preferences, and giving that tool free of charge, might increase the odds of smoking cessation. This trial examines the effectiveness of the ‘STOP’ (Sevrage Tabagique à l’aide d’Outils dédiés selon la Préférence: Smoking cessation using preference-based tools), a preference-based smoking cessation intervention for smokers with low SEP. METHODS AND ANALYSIS: The STOP study is a randomised, multicentre, controlled trial (RCT). Smokers with low SEP and wishing to quit will be randomised to either the intervention or the control group (standard care). Participants in the intervention group will be asked to choose between different types of nicotine substitutes (patches, inhalers, gum, tablets, etc) and/or an electronic cigarette which will be delivered free of charge to aid their smoking cessation attempt. The primary outcome will be smoking abstinence at 6 months after inclusion, defined as self-reported 7-day point prevalence of tobacco abstinence. Secondary outcomes include the total number of days of abstinence at 6 months after inclusion, 7-day point prevalence tobacco abstinence at 1 and 3 months after inclusion and number of relapses. The study will also include an economic evaluation, and a process evaluation using a mixed methods approach. ETHICS AND DISSEMINATION: The study was approved by the ‘Île de France II’ Institutional Review Board on 8 September 2020 (CPP Île de France II; Ref No: 20.01.31.65528 RIPH2 HPS), and results will be published in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT04654585. BMJ Publishing Group 2021-06-30 /pmc/articles/PMC8246378/ /pubmed/34193499 http://dx.doi.org/10.1136/bmjopen-2021-048859 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Addiction
El-Khoury, Fabienne
El Aarbaoui, Tarik
Héron, Mégane
Hejblum, Gilles
Métadieu, Brigitte
Le Faou, Anne-Laurence
Ibanez, Gladys
Melchior, Maria
Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
title Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
title_full Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
title_fullStr Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
title_full_unstemmed Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
title_short Smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
title_sort smoking cessation using preference-based tools among socially disadvantaged smokers: study protocol for a pragmatic, multicentre randomised controlled trial
topic Addiction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246378/
https://www.ncbi.nlm.nih.gov/pubmed/34193499
http://dx.doi.org/10.1136/bmjopen-2021-048859
work_keys_str_mv AT elkhouryfabienne smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT elaarbaouitarik smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT heronmegane smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT hejblumgilles smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT metadieubrigitte smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT lefaouannelaurence smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT ibanezgladys smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial
AT melchiormaria smokingcessationusingpreferencebasedtoolsamongsociallydisadvantagedsmokersstudyprotocolforapragmaticmulticentrerandomisedcontrolledtrial